CAL
GOSS icon

Capital Advisors Ltd’s Gossamer Bio GOSS Stock Holding History

Capital Advisors Ltd’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Hold
0
– – – 1460
2025
Q4 		– Hold
0
– – – 1437
2025
Q3 		– Hold
0
– – – 1439
2025
Q2 		– Hold
0
– – – 1453
2025
Q1 		– Hold
0
– – – 1437
2024
Q4 		– Sell
-2
Closed -$137 – 1463
2024
Q3 		$0 Sell
2
-1
-33% -$77 ﹤0.01% 1476
2024
Q2 		$0 Buy
3
+2
+200% +$120 ﹤0.01% 1492
2024
Q1 		$0 Buy
+1
New +$88 ﹤0.01% 1433
2023
Q4 		– Sell
-3
Closed – – 1369
2023
Q3 		$0 Buy
+3
New +$277 ﹤0.01% 1356

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Capital Advisors Ltd's GOSS Position: Q1 2026 in Review

Capital Advisors Ltd held its Gossamer Bio (GOSS) position steady in Q1 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1460.

Capital Advisors Ltd first reported a position in GOSS in Q3 2023 and has held it in 4 quarters since. The position peaked at $0 in Q3 2024. 181 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Capital Advisors Ltd held 0 shares of Gossamer Bio worth $0 as of Q1 2026.
  • Capital Advisors Ltd left its Gossamer Bio share count unchanged in Q1 2026.
  • Gossamer Bio made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q1 2026, its #1460 holding.
  • Capital Advisors Ltd first reported a position in Gossamer Bio in Q3 2023 and has held it in 4 quarters since.
  • Capital Advisors Ltd's Gossamer Bio position peaked at $0 in Q3 2024.
  • 181 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Capital Advisors Ltd's 13F filing for Q1 2026, filed 16 Apr 2026.